Lincoln Pharmaceuticals Ltd Q1FY22 consolidated net profit higher at Rs. 17.69 crores

Lincoln Pharmaceuticals ltd. has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.124.19 crores during the period ended June 30, 2021 as compared to Rs.82.11 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.17.69 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.12.57 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.8.85 for the period ended June 30, 2021 as compared to Rs.6.29 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 124.19 crs	₹ 82.11 crs	51.25%
Net Profit	₹ 17.69 crs	₹ 12.57 crs	40.73%
EPS	₹ 8.85	₹ 6.29	40.7%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.124.19 crores during the period ended June 30, 2021 as compared to Rs.105.59 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.17.69 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.15.25 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.8.85 for the period ended June 30, 2021 as compared to Rs.7.63 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 124.19 crs	₹ 105.59 crs	17.62%
Net Profit	₹ 17.69 crs	₹ 15.25 crs	16%
EPS	₹ 8.85	₹ 7.63	15.99%

Shares of Lincoln Pharmaceuticals ltd. was last trading in BSE at Rs. 355.95 as compared to the previous close of Rs. 349.1. The total number of shares traded during the day was 19894 in over 1193 trades.

The stock hit an intraday high of Rs. 362.05 and intraday low of 346.55. The net turnover during the day was Rs. 7050022.

Source : Equity Bulls

Keywords